In 1917 was created Nikon, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in Japan. The main department of described Corporate Investor is located in the Minato.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from Nikon is 500 millions - 1 billion dollars. The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Nikon performs on 4 percentage points less the average number of lead investments.
The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Recycling, Medical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Carbon3D, Berkeley Lights, wrnch.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Nikon, startups are often financed by Silver Lake Kraftwerk, Sequoia Capital, TandemLaunch. The meaningful sponsors for the fund in investment in the same round are tella, Shin Nippon Biomedical Laboratories (SNBL), Dainippon Sumitomo Pharma. In the next rounds fund is usually obtained by Sequoia Capital, Walden Riverwood Ventures, Varian.
Related Funds
Fund Name | Location |
ACK Group | - |
Altice SA | Luxembourg, Luxembourg |
China Reform Holdings Corporation | Beijing, Beijing, China |
Creo Medical | Chepstow, United Kingdom, Wales |
Cutting Edge Group | England, London, United Kingdom |
Hualiang Investment Management | China, Shanghai |
Hydra | Amsterdam, Noord-Holland, The Netherlands |
ITX International Holdings | California, Mountain View, United States |
nano bank | Japan, Tokyo |
Quayle Munro | England, London, United Kingdom |
Shaw Venture Partners | Oregon, Portland, United States |
SKG | China, Foshan, Guangdong |
Sustainable Resource Ventures | Concord, Massachusetts, United States |
Tongde Capital | Beijing, Beijing, China |
Twenty One East Victoria Investments | California, Santa Barbara, United States |
Waterland Private Equity | Netherlands, Noord-Holland, North Holland |
Yingke Beite Investment Management Enterprise | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Medmain | $7M | 18 Apr 2024 | Fukuoka, Fukuoka Prefecture, Japan | ||
Asilla | $4M | 12 Sep 2022 | Chiyoda, Japan | ||
LumiThera | $14M | 08 Jul 2020 | Washington, United States | ||
Optocomb | $15M | 21 Feb 2020 | Chiyoda | ||
LumiThera | $10M | 13 Jan 2020 | Washington, United States | ||
wrnch | $7M | 24 Jun 2019 | Quebec | ||
07 May 2018 | Chiyoda, Japan | ||||
GATARI | $364K | 18 Oct 2017 | Chiyoda, Japan | ||
Carbon | $81M | 15 Sep 2016 | Redwood City, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Medmain | $7M | 18 Apr 2024 | Fukuoka, Fukuoka Prefecture, Japan | ||
Asilla | $4M | 12 Sep 2022 | Chiyoda, Japan | ||
LumiThera | $14M | 08 Jul 2020 | Washington, United States | ||
Optocomb | $15M | 21 Feb 2020 | Chiyoda | ||
LumiThera | $10M | 13 Jan 2020 | Washington, United States | ||
wrnch | $7M | 24 Jun 2019 | Quebec | ||
07 May 2018 | Chiyoda, Japan | ||||
GATARI | $364K | 18 Oct 2017 | Chiyoda, Japan | ||
Carbon | $81M | 15 Sep 2016 | Redwood City, California, United States |